✦ LIBER ✦

A trend of improved survival of childhood hepatoblastoma treated with cisplatin and doxorubicin in Taiwanese children

✍ Scribed by Shuenn-Nan Chiu; Yen-Hsuan Ni; Meng-Yao Lu; Dong-Tsamn Lin; Kai-Hsin Lin; Hong-Shiee Lai; Mei-Hwei Chang

Publisher: Springer-Verlag
Year: 2003
Tongue: English
Weight: 292 KB
Volume: 19
Category: Article
ISSN: 0179-0358
DOI: 10.1007/s00383-003-1032-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effectiveness and toxicity of cisplatin

Effectiveness and toxicity of cisplatin and doxorubicin (PLADO) in childhood hepatoblastoma and hepatocellular carcinoma: A siop pilot study

✍ Ninane, Jacques ;Perilongo, Giorgio ;Stalens, Jean-Philippe ;Guglielmi, Maurizio 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 436 KB

Sixteen children, aged 16 days to 13 years with hepatoblastoma (HB) (13 patients) or hepatocellular carcinoma (HCC) (3 patients), were given a total of 89 courses of cisplatin and doxorubicin (PLADO) as IV continuous infusion. All tumors were confined to the liver except for 1 hepatoblastoma patient

Epidemiological factors and survival exp

Epidemiological factors and survival experience in 1770 children with acute leukemia treated by members of children's study group a between 1957 and 1964

✍ Mila I. Pierce; Wayne H. Borges; Ruth Heyn; James A. Wolff; Ethel S. Gilbert 📂 Article 📅 1969 🏛 John Wiley and Sons 🌐 English ⚖ 684 KB

Cyclophosphamide/doxorubicin vs. Cisplat

Cyclophosphamide/doxorubicin vs. Cisplatin/teniposide in the treatment of children older than 12 months of age with disseminated neuroblastoma: A pediatric oncology group randomized phase II study

✍ McWilliams, Nancy B. ;Hayes, F. Ann ;Green, A. A. ;Smith, E. Ide ;Nitschke, Rupr 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 408 KB

## Abstract This prospective study was designed to estimate the response rates and to compare two drug pairs, cyclophosphamide/doxorubicin (Cy/A) and cisplatin/teniposide (P1/VM) in previously untreated patients with disseminated neuroblastoma >12 months of age at diagnosis. Estimated complete clin

Improved long term survival of patients

Improved long term survival of patients with metastatic nonseminomatous testicular germ cell carcinoma in relation to prognostic classification systems during the cisplatin era

✍ Dirk J. A. Sonneveld; Harald J. Hoekstra; Winette T. A. van der Graaf; Wim J. Sl 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 141 KB 👁 2 views

The combination of cisplatin, doxorubici

The combination of cisplatin, doxorubicin, and mitomycin (PAM) compared with the FAM regimen in treating advanced gastric carcinoma: A phase II randomized trial of the Italian oncology group for clinical research

✍ Vincenzo De Lisi; Giorgio Cocconi; Francesco Angelini; Francesco Cavicchi; Franc 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 482 KB 👁 2 views

## BACKGROUND. In a randomized Phase I1 study, the authors evaluated the activity and toxicity of the new cisplatin, doxorubicin, and mitomycin C (PAM) comhination, that includes cisplatin (P) instead of 5-fluorouracil as in the 5-fluorouracil, doxorubicin, and mitomycin C (FAM) Combination, in pat

Survival of children and adolescents wit

Survival of children and adolescents with acute lymphoid leukemia. A study of American Indians and Hispanic and non-Hispanic whites treated in New Mexico (1969 to 1986)

✍ Kathy Foucar; Marilyn H. Duncan; Christine A. Stidley; Charles L. Wiggins; Willi 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 513 KB